URL copied to clipboard

Trending News

UltraTech Cement Sees 35.5% Drop in Q2 FY25 Profit Amid Revenue and EBITDA Decline; Read More for Insights

UltraTech Cement Ltd. reported a Q2 FY25 net profit decline to Rs 825 crore, with revenue down 2.4% to Rs 15,635 crore and EBITDA falling 20.8% to Rs 2,019 crore.

UltraTech Cement Ltd. reported a decline in consolidated net profit for Q2 FY25, with earnings at Rs 825 crore compared to Rs 1,280 crore in the same period last year. The company’s revenue also decreased by 2.4%, totaling Rs 15,635 crore, while EBITDA fell 20.8% to Rs 2,019 crore, resulting in a margin contraction from 15.9% to 12.9%.

Alice Blue Image

Also Read: PNC Infratech Shares Plunge 20% as MoRTH Disqualifies Company from Tenders for One Year; Check Details

Despite a challenging demand environment attributed to the monsoon season, UltraTech’s consolidated sales volume rose by 4% year-on-year to 27.84 million tonnes. However, this represented a significant 14% drop compared to the previous quarter. The domestic grey cement sales realization decreased by 8.4% year-on-year and 2.9% sequentially, averaging Rs 4,901 per million tonnes.

UltraTech reported that, although energy costs decreased by 14%, the EBITDA per unit declined by Rs 244 to Rs 732 per million tonnes. The company achieved a capacity utilization rate of 68% during this quarter, underscoring operational challenges.

Alice Blue Image

As of October 2024, UltraTech’s total cement capacity reached 156.1 million tonnes, with ongoing expansion efforts on schedule. The company has already added 9.9 million tonnes in FY25 and aims to increase capacity by an additional 6.3 million tonnes.

Also Read: RBL Bank Shares Plummet 14% Amid 24% Drop in Q2 Net Profit Due to Asset Quality Concerns; Find Details

Plans for FY26 and FY27 include adding 11.8 million tonnes and 14.7 million tonnes, respectively, bringing the total capacity to 188.9 million tonnes by March 2027. This figure does not account for potential acquisitions pending regulatory approvals. Following the earnings announcement, UltraTech’s shares fell by 2.7% but later stabilized at Rs 10,946, reflecting a 4.24% increase year-to-date and a 29.4% rise over the past year.

Loading
Read More News
Onyx Biotec IPO ने दूसरे दिन 9.11 गुना सब्सक्रिप्शन के साथ भारी रुचि आकर्षित की - अधिक जानकारी पढ़ें!

Onyx Biotec IPO ने दूसरे दिन 9.11 गुना सब्सक्रिप्शन के साथ भारी रुचि आकर्षित की – अधिक जानकारी पढ़ें!

Onyx Biotec IPO को दूसरे दिन 9.11 गुना सब्सक्रिप्शन मिला, जो निवेशकों के मजबूत विश्वास और भारी मांग को दर्शाता